In addition, chemotherapeutic reagents modulate mitogen-activated protein kinase (MAPK) and AKT cascades, which are key signaling pathways associated with cell death and growth inhibition of bladder cancer cells [10,11]. This evidence concerns the gene AKT1 and urinary bladder cancer.